Distinguished in Myocarditis

Jeanette Menger-Schulz

Berlin, BE, DE 
Distinguished in Myocarditis
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Jeanette Menger-Schulz practices in Berlin, Germany. Ms. Menger-Schulz is rated as a Distinguished expert by MediFind in the treatment of Myocarditis. Her top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Myocarditis, Pectus Excavatum, and Aortic Valve Replacement.

Her clinical research consists of co-authoring 235 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 14 articles in the study of Myocarditis.

Gender
Female

Locations

Berlin, BE, Germany
Other Locations
Greifswald, MV, Germany
Buch, BE, Germany
Heidelberg, BW, Germany
Erlangen, BY, Germany
Tuebingen, BW 69120, Germany
Marburg An Der Lahn, HE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Enrollment Status: Active_not_recruiting
Publish Date: December 13, 2024
Intervention Type: Other
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction
Enrollment Status: Unknown
Publish Date: March 07, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

235 Total Publications

Translating the Latest 2025 ESC Guidelines and Consensus Statement into Acute Cardiovascular Care Practice.
Translating the Latest 2025 ESC Guidelines and Consensus Statement into Acute Cardiovascular Care Practice.
Journal: European heart journal. Acute cardiovascular care
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Menger-Schulz's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile